ArticleJournal of radiation research2020
PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation.
Shun-Ichiro Kageyama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it